(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
an approved generic is a separate regulatory product that does not yet exist for semaglutide because of active patents and the peptide biosimilar pathway
Clin Sci Mol Med
He is board certified in Anesthesiology and Pain Medicine and underwent fellowship training in both
Nicht fr den menschlichen Verzehr geeignet
Your provider can assess whether itching reflects injection technique, medication intolerance, a developing allergic reaction, or an unrelated dermatologic condition